Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Sage Therapeutics (SAGE)

Sage Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:SAGE
DateTimeSourceHeadlineSymbolCompany
11/06/202421:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAGESage Therapeutics Inc
11/06/202421:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAGESage Therapeutics Inc
11/06/202421:16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
11/06/202411:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
11/06/202411:30Business WireSage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington’s DiseaseNASDAQ:SAGESage Therapeutics Inc
05/06/202411:30Business WireSage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceNASDAQ:SAGESage Therapeutics Inc
07/05/202411:30Business WireSage Therapeutics to Participate in Upcoming May Investor ConferencesNASDAQ:SAGESage Therapeutics Inc
25/04/202411:30Business WireSage Therapeutics Announces First Quarter 2024 Financial Results and Highlights Pipeline and Business ProgressNASDAQ:SAGESage Therapeutics Inc
17/04/202411:30Business WireSage Therapeutics Announces Topline Results from Phase 2 PRECEDENT Study of Dalzanemdor (SAGE-718) in the Treatment of Mild Cognitive Impairment in Parkinson’s DiseaseNASDAQ:SAGESage Therapeutics Inc
11/04/202411:30Business WireSage Therapeutics to Report First Quarter 2024 Financial Results on Thursday, April 25, 2024NASDAQ:SAGESage Therapeutics Inc
28/02/202411:30Business WireSage Therapeutics to Present at Upcoming March Investor ConferencesNASDAQ:SAGESage Therapeutics Inc
21/02/202421:35Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:SAGESage Therapeutics Inc
15/02/202422:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAGESage Therapeutics Inc
15/02/202422:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAGESage Therapeutics Inc
14/02/202421:09Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:SAGESage Therapeutics Inc
14/02/202412:49Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:SAGESage Therapeutics Inc
14/02/202412:20Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:SAGESage Therapeutics Inc
14/02/202411:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
14/02/202411:30Business WireSage Therapeutics Announces Fourth Quarter and Full Year 2023 Financial Results and Highlights Pipeline and Business ProgressNASDAQ:SAGESage Therapeutics Inc
31/01/202422:25Edgar (US Regulatory)Form SC TO-I/A - Tender offer statement by Issuer: [Amend]NASDAQ:SAGESage Therapeutics Inc
31/01/202421:50Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
31/01/202411:30Business WireSage Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on Wednesday, February 14, 2024NASDAQ:SAGESage Therapeutics Inc
24/01/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
23/01/202413:13Edgar (US Regulatory)Form SC TO-I - Tender offer statement by IssuerNASDAQ:SAGESage Therapeutics Inc
08/01/202411:45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SAGESage Therapeutics Inc
08/01/202411:32Business WireSage Therapeutics to Provide Business Updates at 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:SAGESage Therapeutics Inc
08/01/202411:30Business WireSage Therapeutics Announces Changes to Board of DirectorsNASDAQ:SAGESage Therapeutics Inc
04/01/202421:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SAGESage Therapeutics Inc
02/01/202411:30Business WireSage Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024NASDAQ:SAGESage Therapeutics Inc
19/12/202313:32Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:SAGESage Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:SAGE